ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "treatment and rheumatoid arthritis"

  • Abstract Number: 540 • ACR/ARP Annual Meeting 2019

    Comparing Real-world Retention Rates in a Matched Cohort of Rheumatoid Arthritis Patients Who Either Remained on the Etanercept Originator or Switched to a Biosimilar

    Lisa Baganz1, Anja Strangfeld 2, Peter Herzer 3, Andreas Krause 4, Hans-Peter Tony 5 and Angela Zink 6, 1German Rheumatism Research Center, Berlin, Germany, 2German Rheumatism Research Center (DRFZ), Berlin, Germany, 3Scientific Advisory Board, München, Germany, 4Immanuel Krankenhaus, Berlin, Germany, 5Department of Rheumatology/Clinical Immunology, University Hospital, Wuerzburg, Germany, Würzburg, Germany, 6German Rheumatism Research Centre and Charité University medicine, Berlin, Germany

    Background/Purpose: In Germany, the first etanercept biosimilar was licensed in 2016. In contrast to other European countries there is no uniform recommendation for the prescription…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology